SCHEMBL2979261

SCHEMBL2979261

Cc1ccc(S(=O)(=O)n2cc(/C=C/C(=O)N(C)C)c3cccnc32)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 5/20 0.52
CA9 Q16790 5/20 0.52
L3MBTL1 Q9Y468 2/20 0.46
PTGDR2 Q9Y5Y4 4/20 0.44
KDM4E B2RXH2 1/20 0.44
UBE2N P61088 1/20 0.44
HDAC1 Q13547 2/20 0.41
HDAC2 Q92769 2/20 0.41
HDAC6 Q9UBN7 2/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
HTR6 P50406 2/20 0.39
COMT P21964 1/20 0.38
ENPP3 O14638 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1666448 0.83 CA2 (0.43) CA2CA9L3MBTL1PTGDR2KDM4E
SCHEMBL257136 0.82 KDM4E (0.64) CA2CA9L3MBTL1PTGDR2KDM4E
SCHEMBL20502652 0.80 L3MBTL1 (0.54) CA2CA9L3MBTL1PTGDR2KDM4E
SCHEMBL2979262 0.77 L3MBTL1 (0.46) CA2CA9L3MBTL1PTGDR2KDM4E
SCHEMBL13239579 0.77 L3MBTL1 (0.46) CA2CA9L3MBTL1PTGDR2KDM4E
SCHEMBL2984205 0.76 L3MBTL1 (0.55) CA2CA9L3MBTL1PTGDR2KDM4E
SCHEMBL1779514 0.76 L3MBTL1 (0.60) L3MBTL1PTGDR2KDM4EUBE2NHTR6
SCHEMBL13302164 0.75 L3MBTL1 (0.59) L3MBTL1PTGDR2KDM4EUBE2NHTR6
SCHEMBL2447588 0.74 L3MBTL1 (0.55) CA2CA9L3MBTL1PTGDR2KDM4E
SCHEMBL2024287 0.74 HTR6 (0.56) L3MBTL1PTGDR2KDM4EUBE2NHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100173923-A1 4 (PYRROLOPYRIDINYL)PYRIMIDINYL-2-AMINE DERIVATIVES MERCK PATENT GMBH (DE) 2010-07-08 US disclosed
EP-1996586-A1 4-(PYRROLOPYRIDINYL)PYRIMIDINYL-2-AMINE DERIVATIVES Merck Patent GmbH (DE) 2008-12-03 EP disclosed
WO-2007107221-A1 4-(PYRROLOPYRIDINYL)PYRIMIDINYL-2-AMINE DERIVATIVES MERCK PATENT GMBH (DE) 2007-09-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173923-A1 4 (PYRROLOPYRIDINYL)PYRIMIDINYL-2-AMINE DERIVATIVES MKI67, CDK4, CCNT1 CA2 2517/4885CA9 4281/4885L3MBTL1 862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.